reviewAnnals of OncologySep 14, 2015BRONZE OA

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

JNJarushka NaidooDBDavid B. PageBTBob T. LiLCLouise C. ConnellKSKatja Schindler

Johns Hopkins University · Sidney Kimmel Comprehensive Cancer Center · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,459
total citations
FWCI
62.48
Percentile
100%
References
119
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Medicine
  • Immune checkpoint
  • Melanoma
  • PD-L1
  • Blockade
  • Nivolumab
  • Clinical trial
  • Immunotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.